Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Silva, A. Paz, D. Xisto, M. Lopes-Pacheco, E. Bandeira, M. Vasconcellos, V. Capelozzi, M. Morales, P. Pelosi, E. Cirne-Lima, P. Rocco (Rio de Janeiro, Porto Alegre, Sao Paulo, Brazil; Genova, Italy). Which is the best source of mesenchymal cells to treat acute lung injury?. Eur Respir J 2011; 38: Suppl. 55, 1689

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Understanding the impact of the lung microenvironment to enhance the therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome Source: Eur Respir J, 58 (4) 2100986; 10.1183/13993003.00986-2021 Year: 2021 Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020 Year: 2022 The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004 Late Breaking Abstract - Enhancing the antimicrobial efficacy of mesenchymal stem cells (MSCs) to combat sepsis-induced acute lung injury (ALI) using a novel combination of immune-stimulants Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury}, Source: Eur Respir J 2012; 40: 939-948 Year: 2012 A novel approach for optimal lung recruitment in acute lung injury Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury Year: 2005 A study on markers of pulmonary endothelial cells in acute lung injury induced by bone marrow extract injection inrabbits Source: Eur Respir J 2004; 24: Suppl. 48, 720s Year: 2004 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008 Can kidney injury cause lung injury? Source: Annual Congress 2013 –"Liaisons Dangereuses": the lung and other organs Year: 2013 Mechanical programming of mesenchymal stromal cells to treat lung fibrosis Source: ERS Lung Science Conference 2018 Year: 2018 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010